Side-by-side comparison of AI visibility scores, market position, and capabilities
Insurance-covered virtual dietitian platform matching patients with registered dietitians; expanding into GLP-1 weight loss nutrition support for Ozempic and Wegovy users.
Nourish is a nutrition and registered dietitian platform connecting individuals with virtual dietitian consultations covered by health insurance, making personalized nutrition counseling accessible for chronic disease management, weight loss, and general wellness. Founded in 2021 and headquartered in San Francisco, Nourish raised approximately $44 million to build a telehealth nutrition service that leverages expanding insurance coverage for medical nutrition therapy.
Rare disease biotech developing polytherapy approach for Rett Syndrome (1 in 10,000 girls); founder-developed protocol validated through personal patient experience competing with Acadia Pharmaceuticals Daybue in Rett market.
Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1 in 10,000 girls — applying a polytherapy approach (combining multiple therapeutic agents targeting different disease mechanisms simultaneously) to develop treatments for serious neurological and rare diseases. After improving his daughter's quality of life through a personally developed polytherapy protocol, Auerhahn founded Uncommon Therapeutics to translate these insights into pharmaceutical products for the broader Rett Syndrome patient community.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.